Consistently, analysis of clinical colorectal cancer (CRC) data obtained from the TCGA showed that patients with colon cancers expressing higher levels of REG1CP had worse PFS (Fig. 1k). The gene discussed is REG1CP; the disease is malignant colon neoplasm.